1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Anyone
   


4. For what types of analyses will this data be available?
   Response - Any purpose.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [anagha.gawai@gmail.com].
   


6. For how long will this data be available start date provided 01-10-2024 and end date provided 01-12-2024?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

Aim of the study is to comparative evaluation of vestibular incision subperiosteal tunnel access(VISTA) technique alone and in combination with platelet rich fibrin(PRF) for the treatment of multiple gingival recessions. All the participants will be explained the need and design of the study. Informed and written consent will obtained from the patients. Thorough clinical case history will be recorded. Each patient will undergo ultrasonic scaling (ems) by a single operator. All clinical parameters (PI,BOP,RD,RW,CAL,KTG,RES,PD,PERCENTAGE ROOT COVERAGE) will be measured using UNC 15 periodontal probe(Hufriedy) at baseline, 3 months and 6 months and VAS will be recorded at 1^st day, 10^th day, 3 months and 6 months post surgically. It is a single blind study in which the patient will be randomly assigned to either VISTA (control group) or VISTA with PRF (test group) using manual lottery method. After allotment of the groups following surgical procedure will be performed.

 For control group (VISTA technique)-

  The procedure will be carried out under local anesthesia (lignocaine HCL with 2% epinephrine 1: 200,000). Disinfection of the surgical site will be done with 2% betadine. The vista approach will      begin with the vestibular access incision below mucogingival junction and the location of the access incision will be mesially or distally depending on the sites being treated. The incision is made      through periosteum to elevate a sub periosteal tunnel, exposing the facial osseous plate as well as root dehiscence. This tunnel will be extended at least one or two teeth beyond the teeth                requiring root coverage to mobilize gingival margin and facilitate coronal repositioning. A microsurgical periosteal elevator (vista 4) is used to extend the subperiosteal tunnel. The vista elevator is    introduced through the vestibular access incision and inserted between the periosteum and bone to elevate the periosteum, creating the subperiosteal tunnel. It is important to extend the tunnel      elevation sufficiently beyond the mucogingival margin as well as through the gingival sulcus of the teeth being augmented to allow for low-tension coronal repositioning of the gingiva. Additionally,    the subperiosteal tunnel is extended interproximally under each papilla as far as the embrasure space permitted, without making any surface incisions through the papillae. This subperiosteal          tunnel is repositioned coronally and adapted passively to cej covering the recession defects. Coronally anchored sutures are placed engaging the 2–3 mm apical gingival margin of individual            tooth  using 4-0 silk suture. The suture is secured at the midcoronal point of the facial aspect of each tooth with the help of composite resin button to prevent apical relapse of the gingival margin.    Once coronal stabilization and proper adaptation of the marginal gingiva is achieved then the vertical incision is sutured for the primary closure. Complete surgical site is covered with coe-pack.  

 For test group (VISTA with PRF technique)-

 A) preparation of PRF - around 5 ml of whole venous blood is collected in each of the two sterile vacutainer tubes of 6 ml capacity without anticoagulant. The vacutainer tubes are then placed in a centrifugal machine at 3000 revolutions per minute (rpm) for 10 minutes, after which it settles into the following layers: red lower fraction containing red blood cells, upper straw colored cellular plasma and the middle fraction containing the fibrin clot. The upper straw colored layer is then removed and middle fraction is collected, 2 mm below lower dividing line, which is the prf.

 B) surgical procedure- the same surgical procedure will be carried out as seen in the control group. After the procedure while suturing, coronally anchored sutures will be placed engaging the 2–3 mm apical gingival margin of individual tooth using 4-0 silk suture. The suture is secured at the midcoronal point of the facial aspect of each tooth with the help of composite resin button to prevent apical relapse of the gingival margin. Once coronal stabilization is achieved, freshly prepared prf membrane is inserted through the tunnel using the small periosteal elevator and spread it uniformly on recession defects. After complete and proper adaptation of the membrane the vertical incision is sutured for the primary closure. Complete surgical site is covered with coe-pack.

 The following post-operative measures will be explained to the patients

1) suitable antibiotics (amoxicillin 500mg t.i.d. For 5 days), analgesic (diclofenac sodium 50 mg and paracetamol 500 mg t.i.d. For 5 days) will be prescribed, along with 0.2% chlorhexidine digluconate rinses 10 ml for 1 minute, twice daily for 2 weeks.

2)Sutures will be removed after 10 days postoperatively.

3)Patients will be instructed to avoid usage of toothbrush at surgical site. Teeth cleaning at surgical site will be initiated with gentle brushing with soft toothbrush in coronal direction after suture removal.

4)Each patient will be instructed for proper oral hygiene measure at each appointment. 

All the parameters will be re-evaluated at 3 months and 6 months after surgery by the second blinded operator.